Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Rev Mal Respir ; 40(3): 225-229, 2023 Mar.
Artigo em Francês | MEDLINE | ID: mdl-36740493

RESUMO

Idiopathic pulmonary fibrosis (IPF) is a fatal respiratory disease characterized by severe remodeling of the lung parenchyma, with an accumulation of activated myofibroblasts and extracellular matrix, along with aberrant cellular differentiation. Within the subpleural fibrous zones, ectopic adipocyte deposits often appear. In addition, alterations in lipid homeostasis have been associated with IPF pathophysiology. In this mini-review, we will discuss the potential involvement of the adipocyte secretome and its paracrine or endocrine-based contribution to the pathophysiology of IPF, via protein or lipid mediators in particular.


Assuntos
Adipocinas , Fibrose Pulmonar Idiopática , Humanos , Pulmão , Adipócitos/metabolismo , Lipídeos
2.
Rev Mal Respir ; 32(7): 747-9, 2015 Sep.
Artigo em Francês | MEDLINE | ID: mdl-25480387

RESUMO

INTRODUCTION: Catheter-related infection by non-tuberculous mycobacteria is rare but difficult to diagnose and the treatment is not standardized. CASE REPORT: A 64-year-old woman treated for lung cancer with intravenous chemotherapy developed an infection of her totally implanted perfusion device with Mycobacterium chelonae. The infection was cured after surgical removal of the device and treatment with oral clarithromycin. CONCLUSION: Mycobacteria may infect vascular access devices. Rapid diagnosis of such infections allows early treatment.


Assuntos
Infecções Relacionadas a Cateter/diagnóstico , Infecções por Mycobacterium não Tuberculosas/microbiologia , Administração Oral , Antibacterianos/administração & dosagem , Antineoplásicos/administração & dosagem , Infecções Relacionadas a Cateter/tratamento farmacológico , Claritromicina/administração & dosagem , Infecção Hospitalar , Feminino , Humanos , Infusões Intravenosas , Pessoa de Meia-Idade , Infecções por Mycobacterium não Tuberculosas/tratamento farmacológico , Mycobacterium chelonae/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA